In 2006, Novartis dedicated US$755 million in company citizenship initiatives world wide, specifically specializing in improving access to medicines inside the building world by means of its Use of Medicine tasks, which include donations of medicines to patients impacted by leprosy, tuberculosis, and malaria; Glivec patient support programs; and relief https://pharmaceutical32085.wikiexcerpt.com/3095644/a_review_of_solid_state